Page last updated: 2024-08-21

medroxyprogesterone and Age-Related Osteoporosis

medroxyprogesterone has been researched along with Age-Related Osteoporosis in 30 studies

Research

Studies (30)

Timeframe	Studies, this research(%)	All Research%
pre-1990	11 (36.67)	18.7374
1990's	10 (33.33)	18.2507
2000's	7 (23.33)	29.6817
2010's	2 (6.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ettinger, B; Klein, R; Li, DK	1
Hellier, S	1
Miller, AD	1
Hayashi, T; Ina, K; Maeda, M; Nomura, H	1
Edgardh, K	1
Busen, NH	1
Broomé, U; Hultcrantz, R; Lööf, L; Mallmin, H; Naessén, T; Ormarsdóttir, S; Petrén-Mallmin, M	1
Brenner, PF	1
Anapliotou, ML; Dimitriou, P; Evangelou, EA; Kastanias, IT; Liparaki, M; Psara, P	1
Mattsson, LA; Mellström, D; Obrant, K; Olsson, R	1
Ettinger, B	1
Cromer, B; Harel, Z	1
Beckman, EM; Nachtigall, LE; Nachtigall, RD; Nachtigall, RH	1
Johnson, BE; Lukert, BP; Robinson, RG	1
Stone, R	1
Baylink, DJ; Grecu, EO; Haloran, BP; Simmons, R; Spencer, ME	1
Cagnacci, A; Felipetto, R; Fioretti, P; Gambacciani, M; Melis, GB; Paoletti, AM; Spinetti, A	1
Ames, R; Cundy, T; Evans, M; Reid, IR; Roberts, H; Wattie, D	1
Grecu, EO; Simmons, R; Weinshelbaum, A	1
Haddock, DA	1
Avioli, LV; McCracken, R; McMurtry, C; Pacifici, R; Peck, WA; Rifas, L; Vered, I	1
Adami, S; Bertoldo, F; Lo Cascio, V; Maresca, V; Residori, M; Rossini, M; Suppi, R	1
Bush, TL; Ernster, VL; Huggins, GR; Hulka, BS; Kelsey, JL; Schottenfeld, D	1
Amos, WL	1
Roof, BS	1
Ramont, CB	1
Zussman, L	1
Cali, RW	1
Goisis, M	1

Reviews

4 review(s) available for medroxyprogesterone and Age-Related Osteoporosis

Article	Year
Hormonal contraception: is it worth it? The Nurse practitioner, 2008, Volume: 33, Issue:10 Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Contraindications; Decision Making; Delayed-Action Preparations; Drug Monitoring; Female; Humans; Medroxyprogesterone; Osteoporosis; Patient Education as Topic	2008
Bone mineral density in adolescent women using depot medroxyprogesterone acetate. Journal of the American Academy of Nurse Practitioners, 2004, Volume: 16, Issue:2 Topics: Adolescent; Bone Density; Female; Humans; Medroxyprogesterone; Osteoporosis; Risk Factors	2004
Adolescents: at increased risk for osteoporosis? Clinical pediatrics, 2000, Volume: 39, Issue:10 Topics: Adolescent; Bone Density; Contraceptive Agents, Female; Exercise; Female; Health Status; Humans; Levonorgestrel; Male; Medroxyprogesterone; Nutritional Status; Osteoporosis; Risk Assessment; Sports	2000
Benefits and risks of menopausal estrogen and/or progestin hormone use. Preventive medicine, 1988, Volume: 17, Issue:2 Topics: Breast Neoplasms; Coronary Disease; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Osteoporosis; Progesterone Congeners; Risk Factors; Uterine Neoplasms	1988

Trials

6 trial(s) available for medroxyprogesterone and Age-Related Osteoporosis

Article	Year
The effects of selective estrogen receptor modulator treatment following hormone replacement therapy on elderly postmenopausal women with osteoporosis. Nitric oxide : biology and chemistry, 2011, May-31, Volume: 24, Issue:4 Topics: Adiponectin; Aged; Blood Glucose; Bone Density; Cholesterol, HDL; Cholesterol, LDL; Estriol; Estrogen Replacement Therapy; Female; Humans; Japan; Medroxyprogesterone; Nitric Oxide; Osteoporosis; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tumor Necrosis Factor-alpha	2011
An open, randomized, controlled study of transdermal hormone replacement therapy on the rate of bone loss in primary biliary cirrhosis. Journal of internal medicine, 2004, Volume: 256, Issue:1 Topics: Adult; Aged; Alkaline Phosphatase; Bilirubin; Biomarkers; Bone Density; Calcium; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Femur Neck; Hormone Replacement Therapy; Humans; Hydroxycholecalciferols; Liver; Liver Cirrhosis, Biliary; Lumbar Vertebrae; Medroxyprogesterone; Middle Aged; Osteoporosis; Statistics, Nonparametric; Transaminases	2004
The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: new therapeutic approaches. Clinical endocrinology, 1995, Volume: 42, Issue:3 Topics: Adult; beta-Thalassemia; Chorionic Gonadotropin; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hypogonadism; Male; Medroxyprogesterone; Osteoporosis; Prospective Studies; Regression Analysis; Retrospective Studies; Testosterone	1995
Estrogen-progestogen therapy for low bone mineral density in primary biliary cirrhosis. Liver, 1999, Volume: 19, Issue:3 Topics: Absorptiometry, Photon; Aged; Bone Density; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Lumbar Vertebrae; Medroxyprogesterone; Middle Aged; Osteoporosis; Postmenopause; Time Factors	1999
Estrogen replacement therapy I: a 10-year prospective study in the relationship to osteoporosis. Obstetrics and gynecology, 1979, Volume: 53, Issue:3 Topics: Clinical Trials as Topic; Double-Blind Method; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Menopause; Osteoporosis; Prospective Studies; Time Factors	1979
Transdermal estradiol in the treatment of postmenopausal bone loss. Bone and mineral, 1989, Volume: 7, Issue:1 Topics: Administration, Cutaneous; Alkaline Phosphatase; Bone and Bones; Calcium; Clinical Trials as Topic; Drug Therapy, Combination; Estradiol; Female; Humans; Hydroxyproline; Medroxyprogesterone; Menopause; Middle Aged; Minerals; Osteoporosis; Parathyroid Hormone; Radionuclide Imaging; Random Allocation; Reference Values	1989

Other Studies

20 other study(ies) available for medroxyprogesterone and Age-Related Osteoporosis

Article	Year
Continuation of postmenopausal hormone replacement therapy: comparison of cyclic versus continuous combined schedules. Menopause (New York, N.Y.), 2018, Volume: 25, Issue:11 Topics: Aged; Amenorrhea; Cardiovascular Diseases; Drug Therapy, Combination; Estrogens; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Insurance, Pharmaceutical Services; Kaplan-Meier Estimate; Medroxyprogesterone; Middle Aged; Osteoporosis; Patient Dropouts; Postmenopause; Progesterone; Progestins; Retrospective Studies; Treatment Outcome	2018
Is hormone replacement therapy for me? JAAPA : official journal of the American Academy of Physician Assistants, 2009, Volume: 22, Issue:7 Topics: Colorectal Neoplasms; Contraceptives, Oral, Synthetic; Estrogens; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Hot Flashes; Humans; Medroxyprogesterone; Middle Aged; Osteoporosis; Perimenopause; Treatment Outcome; Vaginitis	2009
[Contraceptive injection Depo-Provera, effect on bones and teenage girls]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2002, Dec-10, Volume: 122, Issue:30 Topics: Adolescent; Bone Density; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Implants; Female; Humans; Medroxyprogesterone; Osteoporosis; Progesterone Congeners	2002
The menopause. The Western journal of medicine, 1982, Volume: 136, Issue:3 Topics: Adult; Aging; Arteriosclerosis; Calcium; Climacteric; Estrogens; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Osteoporosis	1982
Meeting the evolving therapeutic needs of postmenopausal women. Journal of bone and mineral metabolism, 2000, Volume: 18, Issue:5 Topics: Aged; Drug Therapy, Combination; Estrogen Antagonists; Estrogens; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone; Middle Aged; Osteoporosis; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Treatment Outcome	2000
Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1992, Volume: 7, Issue:9 Topics: Absorptiometry, Photon; Adult; Aged; Bone Density; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Prednisone; Retrospective Studies	1992
Depo-Provera. Controversial contraceptive wins approval from FDA panel. Science (New York, N.Y.), 1992, Jun-26, Volume: 256, Issue:5065 Topics: Adult; Breast Neoplasms; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Legislation, Drug; Medroxyprogesterone; Medroxyprogesterone Acetate; Osteoporosis; United States; United States Food and Drug Administration; Uterine Neoplasms	1992
Effects of medroxyprogesterone acetate on some parameters of calcium metabolism in patients with glucocorticoid-induced osteoporosis. Bone and mineral, 1991, Volume: 13, Issue:2 Topics: Aged; Alkaline Phosphatase; Calcifediol; Calcitonin; Calcitriol; Calcium; Humans; Insulin-Like Growth Factor I; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Osteoblasts; Osteocalcin; Osteoporosis; Prednisone	1991
Prevention of postmenopausal bone loss and endometrial responses during a two year prospective study with transdermal 17 beta-estradiol and oral medroxyprogesterone acetate. Annals of the New York Academy of Sciences, 1991, Volume: 622 Topics: Administration, Cutaneous; Administration, Oral; Antineoplastic Agents; Endometrium; Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Osteoporosis	1991
Bone density in women receiving depot medroxyprogesterone acetate for contraception. BMJ (Clinical research ed.), 1991, Jul-06, Volume: 303, Issue:6793 Topics: Absorptiometry, Photon; Adult; Body Mass Index; Bone Density; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Femur Neck; Humans; Lumbar Vertebrae; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Osteoporosis; Risk Factors; Smoking; Time Factors	1991
DMPA and bone density. BMJ (Clinical research ed.), 1991, Aug-24, Volume: 303, Issue:6800 Topics: Bone Density; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Osteoporosis; Research Design	1991
Effective therapy of glucocorticoid-induced osteoporosis with medroxyprogesterone acetate. Calcified tissue international, 1990, Volume: 46, Issue:5 Topics: Aged; Asthma; Bone Density; Humans; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Osteoporosis; Prednisone; Testosterone; Time Factors	1990
A simple way to manage menopause. Postgraduate medicine, 1990, Sep-01, Volume: 88, Issue:3 Topics: Aged; Calcitonin; Calcium; Climacteric; Endometrial Hyperplasia; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Osteoporosis; Physical Exertion; Risk Factors	1990
Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proceedings of the National Academy of Sciences of the United States of America, 1989, Volume: 86, Issue:7 Topics: Adult; Cells, Cultured; Delayed-Action Preparations; Estrogens; Female; Humans; Interleukin-1; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Monocytes; Osteoporosis; Reference Values; Regression Analysis	1989
Pregnancy in a patient with gonadotropin-resistant ovary syndrome. American journal of obstetrics and gynecology, 1985, Sep-15, Volume: 153, Issue:2 Topics: Adult; Chorionic Gonadotropin; Drug Resistance; Estrogens, Conjugated (USP); Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Menopause, Premature; Menotropins; Osteoporosis; Ovarian Diseases; Ovulation; Pregnancy	1985
Treatment of postmenopausal osteoporosis. Annals of internal medicine, 1987, Volume: 106, Issue:5 Topics: Calcium; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Menopause; Osteoporosis	1987
Cyclic hormonetherapy. A report on 305 cases. Geriatrics, 1966, Volume: 21, Issue:11 Topics: Adult; Aged; Breast Neoplasms; Coronary Disease; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Osteoporosis; Uterine Neoplasms; Vaginal Smears	1966
The climacteric. Proceedings of the Royal Society of Medicine, 1973, Volume: 66, Issue:2 Topics: Adolescent; Adult; Age Factors; Aged; Blood Pressure; Castration; Climacteric; Endometrial Hyperplasia; Estradiol; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Hysterectomy; Libido; Male; Medroxyprogesterone; Menopause; Methyltestosterone; Middle Aged; Norethindrone; Osteoporosis; Progesterone	1973
Management of the climacteric and postmenopausal woman. The Medical clinics of North America, 1972, Volume: 56, Issue:3 Topics: Aged; Anxiety; Climacteric; Coronary Disease; Depression; Estrogens; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Neoplasms; Osteoporosis; Ovary; Psychophysiologic Disorders; Vaginitis; Vasomotor System	1972
[Treatment of the preclimacteric and climacteric with a new estrogen-progestin association]. Minerva ginecologica, 1969, Feb-28, Volume: 21, Issue:4 Topics: Carbohydrate Metabolism; Depression; Dysautonomia, Familial; Estrogens; Ethinyl Estradiol; Female; Humans; Hypercholesterolemia; Hypertension; Medroxyprogesterone; Menopause; Middle Aged; Osteoporosis	1969